新聞

• Graybug Appoints Three New Members to its Board of Directors
  25.09.2020 / 14:00 - GlobeNewswire
•  
• Nicox First Half 2020 Financial Results and Business Update
  10.09.2020 / 07:30 - GlobeNewswire
•  
• Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
  08.09.2020 / 22:01 - GlobeNewswire
•  
• Aleafia Health Announces Appointment of Pharmaceutical Executive Tricia Symmes as Chief Commercial Officer
  21.08.2020 / 13:00 - GlobeNewswire
•  
• Wishbone Medical Appoints Jeff George to Board of Directors
  12.08.2020 / 14:01 - GlobeNewswire
•  
• TearClear Raises $22 Million to Advance Multiple Clinical Programs in Development
  11.08.2020 / 13:00 - GlobeNewswire
•  
• Oxurion NV appoints Grace Chang, M.D., Ph.D. as Chief Medical Officer
  03.08.2020 / 08:00 - GlobeNewswire
•  
• Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications
  27.07.2020 / 14:00 - GlobeNewswire
•  
• Verrica Pharmaceuticals Announces Clinical and Drug Development Leadership Changes
  23.07.2020 / 13:30 - GlobeNewswire
•  
• SEC Charges Novartis AG with FCPA Violations
  25.06.2020 / 18:51 - Newsfile Corp
•  
• Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
  08.06.2020 / 15:00 - GlobeNewswire
•  
• CENTOGENE Announces Changes in Senior Management Team
  15.05.2020 / 12:30 - GlobeNewswire
•  
• BioELife Corp. Establishes Advisory Board for Research and Development of Products to Help Defend Against Virus (COVID-19) and Bacteria Contamination
  20.03.2020 / 13:30 - GlobeNewswire
•  
• Nicox to Receive €15 Million and Half of the Cost of the Second NCX 470 Phase 3 Clinical Trial from Ocumension Therapeutics under Amended Agreement
  11.03.2020 / 07:30 - GlobeNewswire
•  
• Precision BioSciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
  10.03.2020 / 12:05 - GlobeNewswire